| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0833 |
| Trial ID | ChiCTR1900027678 |
| Disease | Multiple Myeloma |
| Altered gene | CD19|BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GC012F |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | GC012F injection (BCMA/CD19 CAR-T) in the treatment of recurrent refractory BCMA+ multiple myeloma |
| Year | 2019 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of Anhui Medical University |
| Cohort 1 | |||||||
|
|||||||